Ra Medical closes laser catheter business, focuses on cardiac EP; Q1 rev ~$85k; cash $11M

Catheter Precision, Inc.

Laser catheter business closed; Carlsbad facility shut; related employees terminated.
Preliminary Q1 2023 revenue ~$85k (vs $9k prior year); numbers not comparable due to merger.
New $8M funding; cash approx $11M as of May 1, 2023, prior to CEO severance.
David Jenkins named Interim CEO after Will McGuire resigned; board reduced to 4, director pay cut.
Catheter Precision launched LockeT closure device; VIVO has 70+ target accounts, 125-patient registry.

item 2.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Catheter Precision, Inc. reported quarter ended March 31, 2023 results: revenue $85,000.

Period: quarter ended March 31, 2023
Revenue: $85,000
Result: preliminary results

Exact text from the filing

The registrant is able to preliminarily project revenues of approximately $85,000 for the quarter ended March 31, 2023

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Catheter Precision, Inc. reported quarter ended March 31, 2022 results: revenue $9,000.

Period: quarter ended March 31, 2022
Revenue: $9,000
Result: reported results

Exact text from the filing

revenues of $9,000 were reported in the quarter ended March 31, 2022

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

Catheter Precision, Inc. filing history →

Source: SEC EDGAR

accession 0001654954-23-006726

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.